Along these lines, dihydrexidine, a DRD1 agonist which blocks YAP/TAZ, was effective in reversing the HSC activation of bile duct ligation-induced hepatic fibrosis (Table 1) [7]. The gene discussed is YAP1; the disease is Hepatic fibrosis.